Загрузка...
Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy
Despite recent progress in the development of novel approaches to treat cancer, traditional antineoplastic drugs, such as cisplatin, remain a mainstay of regimens targeting solid tumors. Use of cisplatin is limited by acute kidney injury, which occurs in approximately 30% of patients. Current clinic...
Сохранить в:
| Опубликовано в: : | Exp Biol Med (Maywood) |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5813872/ https://ncbi.nlm.nih.gov/pubmed/29231123 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1535370217745302 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|